Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30

United States Fiscal year ends December CIK 0001472012 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

10 insiders · 39 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Isaac Barchas

Director

—

$18.27M (12) scheduled

−$18.27M

92,211

0.0812%

$2.33M

−89.7%

Max Rosett

Chief Financial Officer

—

$2.52M (3) scheduled

−$2.52M

101,287

0.0892%

$2.56M

+113.3%

Robert Lechleider

Chief Medical Officer

—

$2.34M (5) scheduled

−$2.34M

69,805

0.0615%

$1.77M

—

Kinney Horn

Chief Business Officer

—

$2.30M (2) scheduled

−$2.30M

0

0.0000%

$0.00

—

Clay B Siegall

President and CEO

$1.75M (4)

—

+$1.75M

870,704

0.7666%

$22.05M

+107.5%

Philip Wagenheim

Director

—

$1.34M (2)

−$1.34M

341,147

0.3004%

$8.64M

−16.0%

Jack Higgins

Chief Scientific Officer

—

$538.46K (2) scheduled

−$538.46K

60,250

0.0530%

$1.53M

+314.7%

Philip Tsai

Chief Technical Officer

$204.90K (1)

—

+$204.90K

81,550

0.0718%

$2.06M

—

Jean Jacques Bienaime

Director

$351.43K (6)

$203.82K (2)

+$147.61K

43,415

0.0382%

$1.10M

+161.3%

Sandra G. Stoneman

Chief Legal Officer & GC

—

—

—

43,805

0.0386%

$1.11M

+688.6%